Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far and remember there are only a few more days until the arrival of a long weekend, at least on this side of the pond. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Remember that no prescription is required. Meanwhile, here is the latest menu of tidbits to help you on your way. Have a wonderful day and please do stay in touch …
Alexion Pharmaceuticals is overhauling management and among those leaving is the newly hired chief financial officer, David Anderson. Last November, an unnamed employee charged the drug maker engaged in fraud to hawk its biggest medicine. Alexion then disclosed senior management pressured employees to convince customers to order the drug to meet financial targets and recently hired a new chief executive officer. “We wonder how many major shocks Alexion’s culture and organization can withstand,” Leerink analyst Geoff Porges wrote investors.
About the Author Reprints
